← SynDRA
PF-06840003
SynDRA canonical compound SYN0039266 — structure-anchored drug synonym record
Clinical phase
Phase 1
Primary target(s)
IDO1
Mechanism of action
indoleamine 2,3-dioxygenase inhibitor
All known targets
IDO1
Mechanisms of action (all sources)
IDO1 INHIBITOR
indoleamine 2,3-dioxygenase inhibitor
Cross-references
PubChem CID:
23063810
ChEMBL:
CHEMBL4086143
ChEBI:
233415
TTD: D0J1HB
Synonyms
3-(5-Fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione
PF06840003
2,5-Pyrrolidinedione, 3-(5-fluoro-1H-indol-3-yl)-
3-(5-fluoro-indol-3-yl)-pyrrolidine-2,5-dione
SCHEMBL5463464
GTPL9565
CTK0A0183
DTXSID00630149
MXKLDYKORJEOPR-UHFFFAOYSA-N
KS-000008MY
EX-A1186
EOS200271
AKOS027252536
CS-6186
AS-51973
HY-101111
3-(5-Fluoro-1H-indol-3-yl)-pyrrolidine-2,5-dione
3-(5-fluoro-1H-indol-3- yl)pyrrolidine-2,5-dione
5K1FUI0T2C
RefChem:172265
DTXCID90580902
IDO1 Inhibitor PF-06840003
IDO-1 Inhibitor PF-06840003
Indoleamine 2,3-Dioxygenase Inhibitor PF-06840003
MFCD25121820
UNII-5K1FUI0T2C
orb1302966
SCHEMBL29362517
US9603836, Compound 1
US9603836, Compound 1a
CHEBI:233415
BDBM309529
NSC796100
s8657
CCG-266801
EOS-200271
NSC-796100
SB22834
Look up PF-06840003 in the interactive SynDRA portal →